LEGISLATION
GOOD MANUFACTURING PRACTICES
MANUFACTURING ACTIVITIES
3 billion units of oral solid pharmaceutical forms
Bluepharma is prepared to produce 3 billion units of oral solid pharmaceutical forms (tablets and capsules) per year, making use of up-to-date technology and the latest offer in equipment. Its market competitiveness is also ensured by the use of management techniques based on Lean 6-Sigma methodology.
MANUFACTURING
Manufacturing of oral solid dosage forms
PACKAGING
Packaging operations are performed in accordance with all GMP standards, using cutting edge packaging features.
QUALITY CONTROL
A fully equipped physicochemical and microbiology lab
MANUFACTURING FACILITIES
Bluepharma’s activity goes through the entire value chain of the drug, from R&D to the market.
São Martinho do Bispo
Manufacturing Unit and R&D Centers
Eiras
High Potent Unit. Dedicated Manufacturing site to handle High Potent APIs.
Cernache
Bluepharma Park (masterplan)
3bn
units per year
on time full
reduced lead time
8
packaging line
lean six sigma
right first time
QUALITY CULTURE
Systematically ensuring the quality of manufactured and distributed medicinal products.
Bluepharma is committed to systematically ensuring the quality of manufactured and distributed products; caring for the environment as well as safeguarding the working conditions of its employees, in compliance with Quality, Environment, Health and Safety Systems, supported by the Good Manufacturing Practices, by EMAS, and by other applicable legislation.
EMAS